ÌÇÐÄÆƽâ°æ

Number of medicines in the R&D pipeline for COVID-19 prevention and treatment worldwide as of 2022, by phase

© ÌÇÐÄÆƽâ°æ 2026
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

June 2023

Region

Worldwide

Survey time period

as of September 2022

Supplementary notes

Includes all pipeline medicines that are being developed for market in Canada, the United States, or geographic Europe (excluding Russia and Turkey).

Citation formats

Number of medicines in R&D pipeline worldwide for COVID-19 by phase 2022

Published by A. Minhas, Jun 1, 2023
As of September 2022, around 73 vaccines for COVID-19 were in phase II of development, while 32 vaccines were in phase III. This graph illustrates the number of medicines in the R&D pipeline for COVID-19 prevention and treatment worldwide, by development phase and type of medicine.
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Other statistics that may interest you

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Statistics on

About the industry

10

About the region

10

Selected statistics

10

Other regions

10

Related statistics

10

Further Content: You might find this interesting as well

Topics

Impact of the COVID-19 pandemic on older adults in the U.S.Geriatric health in the U.S.Coronavirus disease (COVID-19) pandemicCoronavirus (COVID-19) in the U.S.Coronavirus (COVID-19) vaccines and treatments
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.